This improvement may be attributed to the heightened radiosensitivity of EGFR-positive NSCLC cells and the ability of cranial RT to efficiently clear intracranial tumours while potentially facilitating better EGFR-TKI penetration through the blood–brain barrier. This evidence concerns the gene EGFR and non-small cell lung carcinoma.